EUVIMEDEUVIMED entdecken
Open Access

Can MRI biomarkers for hearing loss in enlarged vestibular aqueduct be measured reproducibly?

Haroon S Saeed, Azita Rajai, Rachel Dixon, Tejas Kapadia, Iain A Bruce, Stavros Stivaros

The British Journal of Radiology · 10.05.2023

DOI: 10.1259/bjr.20220274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The British Journal of Radiology, online erschienen am 10.05.2023. Verfasst von Haroon S Saeed und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Otolaryngology, Royal Manchester Children's Hospital, Manchester University Hospitals NHS Foundation Trust, Oxford Road, Man…. Hauptthemen laut MEDLINE: Hearing Loss, Sensorineural, Hearing Loss. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Morphological features of an enlarged endolymphatic duct (ED) and sac (ES) are imaging biomarkers for genotype and hearing loss phenotype. We determine which biomarkers can be measured in a reproducible manner, facilitating further clinical prediction studies in enlarged vestibular aqueduct hearing loss.

Methods

A rater reproducibility study. Three consultant radiologists independently measured previously reported MRI ED & ES biomarkers (ED midpoint width, maximal ED diameter closest to the vestibule, ES length, ES width and presence of ES signal heterogeneity) and presence of incomplete partition Type 2 from 80 ears (T 2 weighted axial MRI). Interclass correlation coefficients (ICC) and Gwet’s Agreement Coefficients (AC) were generated to give a measure of reproducibility for both continuous and categorical feature measures respectively.

Results

ES length, width and sac signal heterogeneity showed adequate reproducibility (ICC 95% confidence intervals 0.77–0.95, Gwet’s AC for sac heterogeneity 0.64). When determining ED midpoint width, measurements from multiple raters are required for “good” reliability (ICC 95% CI 0.75–0.89). Agreement on the presence of incomplete partition Type 2 ranged from “moderate” to “substantial”.

Conclusions

Regarding MR imaging, the opinion of multiple expert raters should be sought when determining the presence of an enlarged ED defined by midpoint width. ED midpoint, ES length, width and signal heterogeneity have adequate reproducibility to be further explored as clinical predictors for audiological phenotype. Advances in knowledge: We report which ED & ES biomarkers are reproducibly measured. Researchers can confidently utilise these specific biomarkers when modelling progressive hearing loss associated with enlarged vestibular aqueduct.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hearing Loss, SensorineuralHearing LossRetrospective StudiesVestibular AqueductTomography, X-Ray ComputedBiomarkersReproducibility of ResultsHumansMagnetic Resonance ImagingHypertrophy

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Paediatric Otolaryngology, Royal Manchester Children's Hospital, Manchester University Hospitals NHS Foundation Trust, Oxford Road, Manchester, UK.
  • Research & Innovation, Manchester University NHS Foundation Trust. Oxford Road, Manchester, UK.
  • Centre of Biostatistics, Division of Population Health, University of Manchester, Oxford Road Manchester, Oxford, United Kingdom.
  • Academic Unit of Paediatric Radiology, Royal Manchester Children's Hospital, Manchester University Hospitals NHS Foundation Trust, Oxford Road, Manchester, UK.
  • Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, Oxford Road, Manchester, United Kingdom.
  • Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, medicine & Health, The University of Manchester, Oxford Road, Manchester, United Kingdom.

Zitieren

APA

Saeed, H. S., Rajai, A., Dixon, R., Kapadia, T., Bruce, I. A., & Stivaros, S. (2023). Can MRI biomarkers for hearing loss in enlarged vestibular aqueduct be measured reproducibly?. The British Journal of Radiology. https://doi.org/10.1259/bjr.20220274

Vancouver

Saeed HS, Rajai A, Dixon R, Kapadia T, Bruce IA, Stivaros S. Can MRI biomarkers for hearing loss in enlarged vestibular aqueduct be measured reproducibly?. The British Journal of Radiology. 2023. doi:10.1259/bjr.20220274

BibTeX
@article{Saeed2023,
  author = {Saeed, Haroon S and Rajai, Azita and Dixon, Rachel and Kapadia, Tejas and Bruce, Iain A and Stivaros, Stavros},
  title = {Can MRI biomarkers for hearing loss in enlarged vestibular aqueduct be measured reproducibly?},
  journal = {The British Journal of Radiology},
  year = {2023},
  doi = {10.1259/bjr.20220274}
}
Kostenlos starten →